Medication Assisted Treatment for Opioid Dependence (MATOD) clinical observation opportunity

April 14, 2026

SEMPHN is excited to offer a new paid opportunity for accredited practitioners wanting to gain real-world experience in Medication Assisted Treatment of Opioid Dependence (MATOD). 

Developed in collaboration with Alfred Mental and Addiction Health (AMAH), the MATOD Clinical Placement Program is designed to build the skills and confidence of GPs and NPs who want to provide quality MATOD services to patients who live with Opioid Use Disorder. This new learning opportunity offers funded placements in clinical observation across AMAH’s Specialist Pharmacotherapy Service. 

Program structure:

  • Placements to be offered to GPs and NPs Victoria Wide.
  • Optimal placement for observers is 8x half days for GPs and 4x full days for NPs. This will vary and depend on available activities and your capacity.
  • Placement activities to be agreed prior to start of placement, to support coordination and ensure capacity for discussion and reflection of observation.

Benefits of the program:

  • Hands-on, real-world learning in a highly supportive specialist environment.
  • Start prescribing at a time when your involvement has potential to make a big impact.
  • Generous remuneration for training time.
  • Build on prior MATOD training and experience.
  • Guaranteed exposure to MATOD prescribing.
  • Fit the program into your working week.
Download the flyer

Latest news

March 19, 2026
The General Practice Mental Health Standards Collaboration (GPMHSC) has released updated mental health training standards for 2026–2028, offering clearer guidance on training pathways required by GPs to access Medicare Benefits Schedule (MBS) items related to mental health care under the Better Access Initiative.
March 17, 2026
From April 2026, SEMPHN’s Vulnerable Peoples Homebound Vaccination Program can receive referrals for Flu vaccination only, to eligible homebound individuals. Previously, the Flu vaccination was not available on its own.
March 16, 2026
Statewide referral criteria is now in effect for adult lung nodule conditions in public hospitals.